Kyverna Therapeutics, Inc.
KYTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001994702
No open-market purchases or sales by Kyverna Therapeutics, Inc. insiders were filed in the last 90 days; 120 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
Holders of 5% or more of KYTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kyverna Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Westlake BioPartners Fund I, L.P. | 13G/A | 7.80%4.66M shares | – | Feb 6, 20261 filing | Feb 6, 2026 | SEC |
| GordonMD Global Investments LP | 13G | 7.00%3.06M shares | New | Nov 17, 20251 filing | Nov 17, 2025 | SEC |
| Northpond Ventures III, LP | 13G/A | 6.10%3.47M shares | – | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.10%3.10M shares | New | Jul 29, 20261 filing | Jul 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Kyverna Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20267:00 AM ET | Bain Capital Life Sciences Opportunities III, LP | 13G/A | 4.75%2.88M shares | −0.65 ppfrom 5.40%Below 5% | Jun 30, 2026 | SEC |
| Jul 29, 20263:19 PM ET | BlackRock, Inc. | 13G | 5.10%3.10M shares | New | Jun 30, 2026 | SEC |
| Feb 17, 20266:51 PM ET | Northpond Ventures III, LPand 6 others | 13G/A | 6.10%3.47M shares | – | Dec 31, 2025 | SEC |
| Feb 17, 20264:30 PM ET | Bain Capital Life Sciences Opportunities III, LP | 13G/A | 5.40%3.11M shares | – | Dec 31, 2025 | SEC |
| Feb 6, 20263:17 PM ET | Westlake BioPartners Fund I, L.P.and 4 others | 13G/A | 7.80%4.66M shares | – | Dec 31, 2025 | SEC |
| Nov 17, 20253:41 PM ET | GordonMD Global Investments LPand 4 others | 13G | 7.00%3.06M shares | New | Nov 13, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kyverna Therapeutics, Inc. shares.
No Form 144 notices for Kyverna Therapeutics, Inc. are on file.